156 related articles for article (PubMed ID: 32744369)
21. Different methods of enhancing the efficacy of topical tacrolimus in extra-facial vitiligo: A comparative study.
Esmat SM; Gawdat HI; Hegazy RA; Ahmed FS; Said ER
J Cosmet Dermatol; 2021 Nov; 20(11):3545-3551. PubMed ID: 33626213
[TBL] [Abstract][Full Text] [Related]
22. Treatment of Childhood Vitiligo Using Tacrolimus Ointment with Narrowband Ultraviolet B Phototherapy.
Dayal S; Sahu P; Gupta N
Pediatr Dermatol; 2016 Nov; 33(6):646-651. PubMed ID: 27699846
[TBL] [Abstract][Full Text] [Related]
23. A comparative study on the use of fractional CO
Bakr RM; Abdel-Gaber RM; Tawfik YM
Dermatol Ther; 2021 Jan; 34(1):e14604. PubMed ID: 33249712
[TBL] [Abstract][Full Text] [Related]
24. A randomized prospective study to assess the role of topical tacrolimus as preventive therapy in unstable acral vitiligo.
Kumar D; Thakur V; Subburaj K; Bishnoi A; Vinay K; Sendhil Kumaran M; Parsad D
J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2243-2248. PubMed ID: 37467136
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of topical tacrolimus 0.03% monotherapy in the treatment of non-segmental vitiligo: a randomized, controlled trial.
Saleh R; Ahmed AA; M Abd-Elmagid W
J Cosmet Dermatol; 2021 Dec; 20(12):3943-3952. PubMed ID: 33657259
[TBL] [Abstract][Full Text] [Related]
26. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients.
Fai D; Cassano N; Vena GA
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):916-20. PubMed ID: 17659000
[TBL] [Abstract][Full Text] [Related]
27. Topical tacrolimus for treatment of childhood vitiligo in Asians.
Kanwar AJ; Dogra S; Parsad D
Clin Exp Dermatol; 2004 Nov; 29(6):589-92. PubMed ID: 15550128
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness and safety of topical tacrolimus monotherapy for repigmentation in vitiligo: a comprehensive literature review.
Sisti A; Sisti G; Oranges CM
An Bras Dermatol; 2016 Apr; 91(2):187-95. PubMed ID: 27192518
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the efficacy and safety of 308-nm excimer laser as monotherapy and combination therapy with topical tacrolimus in the treatment of periocular vitiligo.
Zhou F; Chen S; Jin W; Lu Y; Gao Y; Wu J
Dermatol Ther; 2022 Jul; 35(7):e15556. PubMed ID: 35514034
[TBL] [Abstract][Full Text] [Related]
30. The efficacy of adding topical 5-fluorouracil to micro-needling in the treatment of vitiligo: A randomized controlled trial.
Pazyar N; Hatami M; Yaghoobi R; Parvar SY; Radmanesh M; Hadibarhaghtalab M
J Cosmet Dermatol; 2023 May; 22(5):1513-1520. PubMed ID: 36718813
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of the Topical Calcineurin Inhibitors Tacrolimus and Pimecrolimus in the Treatment of Vitiligo in Infants Under 2 Years of Age: A Randomized, Open-Label Pilot Study.
Hu W; Xu Y; Ma Y; Lei J; Lin F; Xu AE
Clin Drug Investig; 2019 Dec; 39(12):1233-1238. PubMed ID: 31522334
[TBL] [Abstract][Full Text] [Related]
32. Vitiligo, NB-UVB and tacrolimus: our experience in Naples.
Baldo A; Lodi G; Di Caterino P; Monfrecola G
G Ital Dermatol Venereol; 2014 Feb; 149(1):123-30. PubMed ID: 24566573
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of fire needle therapy in treating non-segmental stable vitiligo: A randomized self-controlled clinical trial.
Wang Y; Lin M; Huang F; Jia R; Xu W; He Q; Xiong Q; Hu Q; Diao Q; Liu Z
J Cosmet Dermatol; 2024 Jun; ():. PubMed ID: 38894565
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of tretinoin 0.05% cream to prevent hyperpigmentation during narrowband UV-B phototherapy in patients with facial vitiligo: a randomized clinical trial.
Ju HJ; Kim SH; Lee JH; Kim GM; Bae JM
J Dermatolog Treat; 2022 May; 33(3):1738-1741. PubMed ID: 32869680
[TBL] [Abstract][Full Text] [Related]
35. Once-daily application of calcipotriene 0.005%-betamethasone dipropionate 0.064% ointment for repigmentation of facial vitiligo.
Newman MD; Silverberg NB
Cutis; 2011 Nov; 88(5):256-9. PubMed ID: 22272490
[TBL] [Abstract][Full Text] [Related]
36. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo.
Rodríguez-Martín M; García Bustínduy M; Sáez Rodríguez M; Noda Cabrera A
Br J Dermatol; 2009 Feb; 160(2):409-14. PubMed ID: 19016706
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of a combined 308-nm excimer lamp and topical mid-potent steroid treatment for facial vitiligo: a preliminary, randomized double-blinded controlled study.
Juntongjin P; Toncharoenphong N
Lasers Med Sci; 2020 Dec; 35(9):2023-2029. PubMed ID: 32458080
[TBL] [Abstract][Full Text] [Related]
38. Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study.
Shah S; Sakhiya J; Deshpande P; Sakhiya D; Inamadar AC
J Clin Aesthet Dermatol; 2020 Feb; 13(2):E69-E75. PubMed ID: 32308788
[No Abstract] [Full Text] [Related]
39. FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo.
Lan CC; Chen GS; Chiou MH; Wu CS; Chang CH; Yu HS
Br J Dermatol; 2005 Sep; 153(3):498-505. PubMed ID: 16120133
[TBL] [Abstract][Full Text] [Related]
40. A pilot comparative study of topical latanoprost and tacrolimus in combination with narrow-band ultraviolet B phototherapy and microneedling for the treatment of nonsegmental vitiligo.
Korobko IV; Lomonosov KM
Dermatol Ther; 2016 Nov; 29(6):437-441. PubMed ID: 27329330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
